Funding awarded
- Genetic and pharmacologic inhibition of ALDH1A3 as a treatment of beta cell failure awarded by National Institute of Diabetes & Digestive & Kidney Diseases Principal Investigator 2025 - 2027
- missing activity Principal Investigator Subaward 2026 - 2026